Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4407401000168119 | Xativa (cannabidiol 12.5 mg) sublingual wafer, 30 wafers (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4407411000168116 | Xativa 12.5 mg sublingual wafer, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xativa 12.5 mg sublingual wafer, 30 | Is a | cannabidiol 12.5 mg sublingual wafer, 30 | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer, 30 | has TP | Xativa | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer, 30 | has TPUU | Xativa 12.5 mg sublingual wafer | true | Inferred relationship | Some | 1512177763 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xativa 12.5 mg sublingual wafer, 30, blister pack | Is a | True | Xativa 12.5 mg sublingual wafer, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR